ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   


By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

American Academy of Neurology 

1080 Montreal Avenue

St. Paul  Minnesota  55116  U.S.A.
Phone: 651-695-1940 Fax: 651-695-2791


SEARCH JOBS








 Company News
Synthetic Biologics, Inc. (SYN) Announces Rhonda Voskuhl, M.D., To Present Trimesta™ Phase II Multiple Sclerosis Clinical Trial Results At The 2014 American Academy of Neurology Annual Meeting 2/10/2014 10:08:46 AM    More...
Does Migraine Affect Income or Income Affect Migraine? American Academy of Neurology Reveals 8/29/2013 6:44:26 AM    More...
Addex Therapeutics (ADXN.SW) Announces Presentation of Dipraglurant Phase 2a Study Results at the 2013 Annual Meeting of the American Academy of Neurology 3/22/2013 8:50:49 AM    More...
Daval International Limited CSO Presents Results From an Exploratory Clinical Trial of AIMSPRO in Amyotrophic Lateral Sclerosis (ALS) at American Academy of Neurology Annual Meeting 3/21/2013 12:05:23 PM    More...
ACADIA Pharmaceuticals, Inc. (ACAD) Announces Presentation of Data From Its Pivotal Phase III Parkinson's Disease Psychosis Study With Pimavanserin at the American Academy of Neurology Annual Meeting 3/21/2013 10:55:29 AM    More...
Data From Isis Pharmaceuticals, Inc. (ISIS)-SMN Rx Phase 1 Study in Children With Spinal Muscular Atrophy Presented at the American Academy of Neurology Meeting 3/21/2013 9:51:55 AM    More...
BioTie Therapies Corp. Presents Tozadenant Phase 2b Data at American Academy of Neurology Annual Meeting 3/21/2013 9:51:03 AM    More...
Orion Corporation Presented Promising Phase II Data for New Alzheimer's Disease Drug at American Academy of Neurology Annual Meeting 3/21/2013 9:49:18 AM    More...
Adamas Pharmaceuticals Presents New Traumatic Brain Injury Data From Its Nurelin™ Program at American Academy of Neurology Conference 3/20/2013 9:21:41 AM    More...
Chelsea Therapeutics, Inc. (CHTP) Announces Presentation of Northera™ (droxidopa) Study 306 Data at the American Academy of Neurology Annual Meeting 3/19/2013 11:05:06 AM    More...
12345678910...